These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30224724)

  • 41. Intracellular membrane localization of pseudomonas ExoS and Yersinia YopE in mammalian cells.
    Krall R; Zhang Y; Barbieri JT
    J Biol Chem; 2004 Jan; 279(4):2747-53. PubMed ID: 14597627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epithelial cell lysates induce ExoS expression and secretion by Pseudomonas aeruginosa.
    Hritonenko V; Metruccio M; Evans D; Fleiszig S
    FEMS Microbiol Lett; 2018 Apr; 365(8):. PubMed ID: 29518189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The GAP portion of Pseudomonas aeruginosa type III secreted toxin ExoS upregulates total and surface levels of wild type CFTR.
    Tukaye DN; Kwon SH; Guggino WB
    Cell Physiol Biochem; 2013; 31(1):153-65. PubMed ID: 23428533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Type III Secretion System of Pseudomonas aeruginosa Affects Matrix Metalloproteinase 12 (MMP-12) and MMP-13 Expression via Nuclear Factor κB Signaling in Human Carcinoma Epithelial Cells and a Pneumonia Mouse Model.
    Park JW; Kim YJ; Shin IS; Kwon OK; Hong JM; Shin NR; Oh SR; Ha UH; Kim JH; Ahn KS
    J Infect Dis; 2016 Sep; 214(6):962-9. PubMed ID: 27377745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
    Finck-Barbançon V; Goranson J; Zhu L; Sawa T; Wiener-Kronish JP; Fleiszig SM; Wu C; Mende-Mueller L; Frank DW
    Mol Microbiol; 1997 Aug; 25(3):547-57. PubMed ID: 9302017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung.
    Shaver CM; Hauser AR
    Infect Immun; 2004 Dec; 72(12):6969-77. PubMed ID: 15557619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
    Han S; Arvai AS; Clancy SB; Tainer JA
    J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-activity relationships for inhibitors of Pseudomonas aeruginosa exoenzyme S ADP-ribosyltransferase activity.
    Saleeb M; Sundin C; Aglar Ö; Pinto AF; Ebrahimi M; Forsberg Å; Schüler H; Elofsson M
    Eur J Med Chem; 2018 Jan; 143():568-576. PubMed ID: 29207339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of Vis Toxin, a Novel ADP-Ribosyltransferase from Vibrio splendidus.
    Ravulapalli R; Lugo MR; Pfoh R; Visschedyk D; Poole A; Fieldhouse RJ; Pai EF; Merrill AR
    Biochemistry; 2015 Sep; 54(38):5920-36. PubMed ID: 26352925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras.
    Henriksson ML; Rosqvist R; Telepnev M; Wolf-Watz H; Hallberg B
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):217-22. PubMed ID: 10727422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa.
    Yahr TL; Barbieri JT; Frank DW
    J Bacteriol; 1996 Mar; 178(5):1412-9. PubMed ID: 8631719
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular mechanisms of the cytotoxicity of ADP-ribosylating toxins.
    Deng Q; Barbieri JT
    Annu Rev Microbiol; 2008; 62():271-88. PubMed ID: 18785839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell-type-specific hypertranslocation of effectors by the Pseudomonas aeruginosa type III secretion system.
    Armentrout EI; Kundracik EC; Rietsch A
    Mol Microbiol; 2021 Feb; 115(2):305-319. PubMed ID: 33012037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pseudomonas aeruginosa Effector ExoS Inhibits ROS Production in Human Neutrophils.
    Vareechon C; Zmina SE; Karmakar M; Pearlman E; Rietsch A
    Cell Host Microbe; 2017 May; 21(5):611-618.e5. PubMed ID: 28494242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Eukaryotic cell determination of ExoS ADP-ribosyltransferase substrate specificity.
    Fraylick JE; Rucks EA; Greene DM; Vincent TS; Olson JC
    Biochem Biophys Res Commun; 2002 Feb; 291(1):91-100. PubMed ID: 11829467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pseudomonas aeruginosa ExoT ADP-ribosylates CT10 regulator of kinase (Crk) proteins.
    Sun J; Barbieri JT
    J Biol Chem; 2003 Aug; 278(35):32794-800. PubMed ID: 12807879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biochemical relationships between the 53-kilodalton (Exo53) and 49-kilodalton (ExoS) forms of exoenzyme S of Pseudomonas aeruginosa.
    Liu S; Yahr TL; Frank DW; Barbieri JT
    J Bacteriol; 1997 Mar; 179(5):1609-13. PubMed ID: 9045820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Crystal structure and site-directed mutagenesis of enzymatic components from Clostridium perfringens iota-toxin.
    Tsuge H; Nagahama M; Nishimura H; Hisatsune J; Sakaguchi Y; Itogawa Y; Katunuma N; Sakurai J
    J Mol Biol; 2003 Jan; 325(3):471-83. PubMed ID: 12498797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delineation of exoenzyme S residues that mediate the interaction with 14-3-3 and its biological activity.
    Yasmin L; Jansson AL; Panahandeh T; Palmer RH; Francis MS; Hallberg B
    FEBS J; 2006 Feb; 273(3):638-46. PubMed ID: 16420486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin.
    Barbieri JT
    Int J Med Microbiol; 2000 Oct; 290(4-5):381-7. PubMed ID: 11111915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.